1. A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen. Issue 10 (3rd March 2023) Authors: Baek, Yae Jee; Kim, Woo-Joong; Ko, Jae-Hoon; Lee, Youn-Jung; Ahn, Jin Young; Kim, Jung Ho; Jang, Ho Cheol; Jeong, Hye Won; Kim, Yong Chan; Park, Yoon Soo; Kim, Sung-Han; Peck, Kyong Ran; Shin, Eui-Cheol; Choi, Jun Yong Journal: Vaccine Issue: Volume 41:Issue 10(2023) Page Start: 1694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗